Last reviewed · How we verify
NCT07070154
Evaluating the Efficacy of a Text Messaging-based Shisha Smoking Cessation Intervention for Young Adults in Hong Kong: A Randomised Controlled Pilot Trial
NA trial testing text-messaging based intervention in Intervention in 100 participants. Not yet recruiting.
1 May 2026
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 100 |
| Start date | 20 July 2025 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- text-messaging based intervention
Conditions studied
- Intervention — all drugs for Intervention →
- Control — all drugs for Control →
Sponsor
The University of Hong Kong
Who can join
Adults 18 to 35, any sex, with Intervention or Control. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
shisha abstinences
Time frame: From enrollment, 6-week (after treatment) and 12-week follow-up
To compare the self-reported shisha abstinences between intervention and control group to evaluate the efficacy of the culture specific text-messaging based shisha smoking cessation intervention. Shisha abstinence is determined by self-reported last use 1) in the past 7 days using the Timeline Followback Method for active use, 2) in the past 30 days to determine current use, and 3) in the past 90
Sponsor's own description
The goal of this study is to evaluate the efficacy of a culture specific text-messaging based shisha smoking cessation intervention for young adults in Hong Kong. Participants in the intervention group will receive smartphone text messaging-based intervention and support that contained personalised messages with both text and visual elements over 6 weeks under a manualised programme. Participants in the control group will only receive a leaflet about the health risks of shisha smoking (the exact identical contents received by the participants in the intervention group at a session). All participants will complete a self-administered questionnaire at baseline, 6th- and 12th-week on their self-reported shisha abstinences, knowledge on risk, readiness to quit and attitudes on shisha smoking
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07070154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intervention
Currently open trials in the same condition.
- NCT06978959 — Family Navigator Plus for Foster Parents · NA · recruiting
- NCT07361211 — A Multifaceted Intervention to Reduce Obesity Among Preschool Children: Study Protocol for a Randomized Controlled Trial · NA · active not recruiting
- NCT06750107 — Testing the Efficacy of Safe South Africa · Phase 3 · active not recruiting
- NCT07113626 — Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam · NA · recruiting
- NCT06515574 — Effect of Developmental Care on Very Low Birth Weight Infants · NA · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07070154 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 14 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07070154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing